EDGAR Filing Documents for 0001104659-17-002173

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001104659-17-002173

Filing Date

2017-01-12

Accepted

2017-01-12 17:27:23

Documents

Effectiveness Date

2017-01-12

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	a17-1933_1s8.htm	S-8	132219
2	EX-5.1	a17-1933_1ex5d1.htm	EX-5.1	42238
3	EX-23.1	a17-1933_1ex23d1.htm	EX-23.1	2403
4	EX-23.2	a17-1933_1ex23d2.htm	EX-23.2	2423
5	GRAPHIC	g19331kei001.jpg	GRAPHIC	8132
6	GRAPHIC	g19331kei002.jpg	GRAPHIC	21362
7	GRAPHIC	g19331kei003.jpg	GRAPHIC	1863
	Complete submission text file	0001104659-17-002173.txt		223960

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: S-8 | Act: 33 | File No.: 333-215532 | Film No.: 17525998
SIC: 2834 Pharmaceutical Preparations